UBS Maintains Neutral on Stem, Lowers Price Target to $7
UBS analyst Jon Windham maintains Stem (NYSE:STEM) with a Neutral and lowers the price target from $10.5 to $7.
Stocks · News reference
Stem Affirms FY2026 Sales Guidance of $140.000M-$190.000M vs $160.232M Est
Stem (NYSE:STEM) affirms FY2026 sales outlook from $140.000 million-$190.000 million to $140.000 million-$190.000 million vs $160.232 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stem shares are trading higher after the company reported better-than-expected Q2 EPS results.
8-K filing — STEM, INC. (STEM)
Filed: 2026-08-12 AccNo: 0001758766-26-000078 Size: 559 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stem Q2 EPS $(1.58) Beats $(1.99) Estimate, Sales $33.654M Miss $35.497M Estimate
Stem (NYSE:STEM) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(1.99) by 20.6 percent. This is a 11.73 percent increase over losses of $(1.79) per share from the same